StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Zenas BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zenas BioPharma's price to sales ratio was 105.3× on Apr 30, 2026, against 96.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026105.3×+3.1
2025Dec 31, 2025102.2×–

More Zenas BioPharma figures

See a number that looks wrong?